Free Trial

Getinge AB (publ) Q3 2023 Earnings Report

Getinge AB (publ) logo
$15.83 +0.14 (+0.89%)
(As of 12/20/2024 05:55 PM ET)

Getinge AB (publ) EPS Results

Actual EPS
$0.25
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Getinge AB (publ) Revenue Results

Actual Revenue
$703.75 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Getinge AB (publ) Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

Getinge AB (publ) Earnings Headlines

Getinge price target lowered to SEK 180 from SEK 190 at JPMorgan
Has Trump Finally Gone Too Far?
Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.
Kepler Capital Reaffirms Their Hold Rating on Getinge (0GZV)
See More Getinge AB (publ) Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Getinge AB (publ)? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Getinge AB (publ) and other key companies, straight to your email.

About Getinge AB (publ)

Getinge AB (publ) (OTCMKTS:GNGBY) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

View Getinge AB (publ) Profile

More Earnings Resources from MarketBeat

Upcoming Earnings